Global CSR Program
Forecasted
Global CSR Program supports philanthropic partners through Takeda Pharmaceuticals, funding initiatives that aim to improve patient outcomes while tracking progress against stated objectives.
This grant was recently updated
Takeda now says the FY2027 RFP schedule will be posted once confirmed and is refining its application process. It removed the three climate-health proposal tracks, weighted review criteria, summary-slide requirement, and July notification/September announcement timing; employee-voting details are now marked “To be updated.”
Funder: Takeda Pharmaceuticals
Due Dates (Anticipated): March 2027 (FY2027 RFP deadline)
Funding Amounts: Award amounts and project durations will be specified in the applicable RFP.
Summary: Supports philanthropic initiatives that improve patient outcomes through Takeda’s Global CSR Program.
Key Information: All proposals must be submitted in English through the Digital CSR Donation Management System.
Description
Takeda Pharmaceuticals’ Global CSR Program supports philanthropic initiatives aimed at improving patient outcomes. Marking its tenth anniversary in 2026, the program is evolving its approach to maximize impact and refining its request for proposal (RFP) process in response to feedback from partners and collaborators. The applicable RFP sets out thematic priorities, eligibility criteria, technical guidance, and the complete proposal timeline.
The program pairs philanthropic support with monitoring and evaluation against each initiative’s stated objectives and results framework. Awardees track and report progress, while Takeda reviews performance and learning through conversations with awardees, progress-report reviews, and learning-trip site visits.
